Liquidia Technologies (LQDA)
(Real Time Quote from BATS)
$12.42 USD
+0.05 (0.40%)
Updated Apr 26, 2024 11:19 AM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Price, Consensus and EPS Surprise
LQDA 12.42 +0.05(0.40%)
Will LQDA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for LQDA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LQDA
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline
LQDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
Other News for LQDA
Commit To Purchase Liquidia Corp At $7.50, Earn 15.5% Annualized Using Options
Commit To Buy Liquidia Corp At $10, Earn 28% Annualized Using Options
Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
Buy Rating for Liquidia Technologies: Innovation and Market Potential Drive Strong Investment Case
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference